Isorhamnetin Inhibits Proliferation and Invasion and Induces Apoptosis through the Modulation of Peroxisome Proliferator-activated Receptor [gamma] Activation Pathway in Gastric Cancer
MetadataShow full item record
Gastric cancer (GC) is a lethal malignancy and the second most common cause of cancer-related deaths. Although treatment options such as chemotherapy, radiotherapy, and surgery have led to a decline in the mortality rate due to GC, chemoresistance remains as one of the major causes for poor prognosis and high recurrence rate. In this study, we investigated the potential effects of isorhamnetin (IH), a 3-O-methylated metabolite of quercetin on the peroxisome proliferator-activated receptor (PPAR-) signaling cascade using proteomics technology platform, GC cell lines, and xenograft mice model. We observed that IH exerted a strong antiproliferative effect and increased cytotoxicity in combination with chemotherapeutic drugs. IH also inhibited the migratory/invasive properties of GC cells, which could be reversed in the presence of PPAR- inhibitor. We found that IH increased PPAR- activity and modulated the expression of PPAR- regulated genes inGC cells. Also, the increase in PPAR- activity was reversed in the presence of PPAR--specific inhibitor and a mutated PPAR- dominant negative plasmid, supporting our hypothesis that IH can act as a ligand of PPAR-. Using molecular docking analysis, we demonstrate that IH formed interactions with seven polar residues and six nonpolar residues within the ligand-binding pocket of PPAR- that are reported to be critical for its activity and could competitively bind to PPAR-. IH significantly increased the expression of PPAR- in tumor tissues obtained from xenograft model of GC. Overall, our findings clearly indicate that antitumor effects of IH may be mediated through modulation of the PPAR- activation pathway in GC.
Showing items related by title, author, creator and subject.
Woo, C.; Loo, S.; Gee, V.; Yap, C.; Sethi, G.; Kumar, Alan Prem; Benny Tan, K. (2011)Thymoquinone (TQ), an active ingredient of Nigella sativa, has been reported to exhibit anti-oxidant, anti-inflammatory and anti-tumor activities through mechanism(s) that is not fully understood. In this study, we report ...
PPAR gamma Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast CancersChen, L.; Yuan, Y.; Kar, S.; Kanchi, M.; Arora, S.; Kim, J.; Koh, P.; Yousef, E.; Samy, R.; Shanmugam, M.; Tan, T.; Shin, S.; Arfuso, Frank; Shen, H.; Yang, H.; Goh, B.; Park, J.; Gaboury, L.; Lobie, P.; Sethi, G.; Lim, L.; Kumar, Alan Prem (2017)Metastatic breast cancer is still remain incurable so far, new specifically targeted and more effective therapies for triple negative breast cancer (TNBC) are required in the clinic. In this study, our clinical data has ...
PPARγ Ligand–induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast CancersChen, L.; Yuan, Y.; Kar, S.; Kanchi, M.; Arora, S.; Kim, J.; Koh, P.; Yousef, E.; Samy, R.; Shanmugam, M.; Tan, T.; Shin, S.; Arfuso, Frank; Shen, H.; Yang, H.; Goh, B.; Park, J.; Gaboury, L.; Lobie, P.; Sethi, G.; Lim, L.; Kumar, A. (2017)Metastatic breast cancer is still incurable so far; new specifically targeted and more effective therapies for triple-negative breast cancer (TNBC) are required in the clinic. In this study, our clinical data have established ...